Journal Article
Uptake of Infliximab Biosimilars Among the Medicare Population
July 20, 2020
Featured Experts: Alice Chen, PhD, Karen Van Nuys, PhD
Research
All Research Featured Research
News
Two Years After Launch, Biosimilars for Rheumatoid Arthritis and Other Lifelong Conditions Captured Little Market Share
July 20, 2020
Featured Experts: Karen Van Nuys, PhD, Alice Chen, PhD
News
Coronavirus Treatments, Not Just Vaccines, Will Save Lives and Generate Value
July 9, 2020
Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD, Desi Peneva, MS, Geoffrey Joyce, PhD
White Paper
The Value of Treatment for COVID-19
July 8, 2020
Featured Experts: Karen Mulligan, PhD, Karen Van Nuys, PhD, Desi Peneva, MS, Geoffrey Joyce, PhD
Journal Article
Provider Differences in Biosimilar Uptake in the Filgrastim Market
March 26, 2020
Featured Experts: Alice Chen, PhD, Karen Van Nuys, PhD
News
New Evidence Shows Prescription Drug Rebates Play a Role in Increasing List Prices
February 11, 2020
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
White Paper
The Association Between Drug Rebates and List Prices
February 11, 2020
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD
Journal Article
A New Model for Pricing Drugs of Uncertain Efficacy
December 13, 2018
Featured Experts: Dana Goldman, PhD, Karen Van Nuys, PhD, Jakub Hlávka, PhD
News
White House Signs Bills Banning Gag Clauses, Schaeffer Center Research Pivotal in Discussion
October 25, 2018
Featured Experts: Karen Van Nuys, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
News
Who Wins When a Prescription Copay Exceeds the Drug Price? (Not the Patient)
July 18, 2018
Featured Experts: Karen Van Nuys, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
Journal Article
Innovation in Heart Failure Treatment: Life Expectancy, Disability, and Health Disparities
April 1, 2018
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD
News
Study Finds Consumer Copays Frequently Exceed Cost of Common Prescriptions
March 15, 2018
Featured Experts: Karen Van Nuys, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
Journal Article
Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs
March 14, 2018
Featured Experts: Karen Van Nuys, PhD, Geoffrey Joyce, PhD
Data Visualization
Overpaying for Prescription Drugs: The Copay Clawback Phenomenon
March 13, 2018
Featured Experts: Karen Van Nuys, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
Perspective
Prescription Drug Coupons: A One-Size-Fits-All Policy Approach Doesn’t Fit The Evidence
February 20, 2018
Featured Experts: Geoffrey Joyce, PhD, Karen Van Nuys, PhD
White Paper
Prescription Drug Copayment Coupon Landscape
February 7, 2018
Featured Experts: Karen Van Nuys, PhD, Geoffrey Joyce, PhD, Dana Goldman, PhD
White Paper
Reining in Pharmaceutical Costs
January 13, 2018
Featured Experts: Karen Van Nuys, PhD, Dana Goldman, PhD
Perspective
Follow the Money to Understand How Drug Profits Flow
December 15, 2017
Featured Experts: Neeraj Sood, PhD, Dana Goldman, PhD, Karen Van Nuys, PhD
Perspective
Follow the Money: The Flow of Funds in the Pharmaceutical Distribution System
June 13, 2017
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD, Dana Goldman, PhD
News
New Report Documents the Flow of Money Through the Pharmaceutical Distribution Chain
June 13, 2017
Featured Experts: Neeraj Sood, PhD, Karen Van Nuys, PhD, Dana Goldman, PhD
- ← Previous
- 1
- 2
- 3
- 4
- Next →